Why the study?
The study aimed to evaluate the safety and efficacy of continuous renal replacement therapy during PCI in patients with severe acute myocardial infarction.
Does perioperative continuous renal replacement therapy improve clinical and laboratory markers of cardiac, renal, and liver function in severe acute myocardial infarction patients undergoing percutaneous coronary intervention?
Does perioperative continuous renal replacement therapy improve clinical and laboratory markers of cardiac, renal, and liver function in severe acute myocardial infarction patients undergoing percutaneous coronary intervention?
Perioperative continuous renal replacement therapy during PCI in severe AMI patients is associated with improved cardiac, renal, and liver function markers.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for perioperative CRRT in severe AMI-PCI; prospective RCTs needed before clinical adoption.
This retrospective study aimed to evaluate the safety and efficacy of continuous renal replacement therapy (CRRT) during percutaneous coronary intervention (PCI) in patients with severe acute myocardial infarction (AMI). The study analyzed data from 945 AMI patients hospitalized between January 2016 and December 2017, out of which 21 patients underwent perioperative CRRT for PCI. We assessed the baseline characteristics of severe AMI patients before and after CRRT and examined the effect of CRRT on cardiac, renal, and liver function, as well as other indicators. The heart rate of patients undergoing CRRT was significantly lower at 24 h and 48 h after CRRT than before CRRT (p=0.038). There was a moderate but not significant decrease in the mean systolic blood pressure or diastolic blood pressure (p>0.05). Importantly, we found that significantly more patients showed Killip class I-II and significantly improved cardiac function after CRRT (23.8% vs. 57.1%, p=0.001). The levels of urea nitrogen, creatinine, aspartate aminotransferase, glutamic pyruvic transaminase, and total bilirubin were significantly lowered after CRRT treatment (p<0.05). Perioperative management of CRRT was safe and effective for severe AMI patients.
No takes yet. Share an insight, caveat, or question.
Shang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: